Conor Medsystems Stockholders Approve Merger Agreement with Johnson & Johnson
31 Enero 2007 - 3:01PM
PR Newswire (US)
MENLO PARK, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Conor
Medsystems, Inc. (NASDAQ:CONR) today announced that Conor
Medsystems stockholders approved the merger agreement between Conor
Medsystems, Johnson & Johnson (NYSE:JNJ) and a wholly owned
subsidiary of Johnson & Johnson. The proposed transaction is
expected to close within the next few days, subject to the
satisfaction of the remaining closing conditions Under the terms of
the merger agreement, Conor Medsystems' stockholders will be
entitled to receive $33.50 for each outstanding share of Conor
Medsystems common stock. Conor Medsystems develops innovative
controlled vascular drug delivery technologies, and has primarily
focused on the development of drug-eluting stents to treat coronary
artery disease. For further information on Conor Medsystems and
controlled vascular delivery, visit http://www.conormed.com/. (This
press release contains "forward-looking statements" as defined in
the Private Securities Litigation Reform Act of 1995. These
statements are based on current expectations of future events. If
underlying assumptions prove inaccurate or unknown risks or
uncertainties materialize, actual results could vary materially
from Conor Medsystems' expectations and projections. Risks and
uncertainties include the satisfaction of the remaining closing
conditions and the possibility that the transaction will not be
completed. A list and description of the risks and uncertainties
confronting Conor Medsystems can be found in Conor Medsystems'
Quarterly Report on Form 10-Q for the quarter ended September 30,
2006. This filing as well as subsequent filings are available
online at http://www.sec.gov/ or on request from Conor Medsystems.
Conor Medsystems does not undertake to update any forward-looking
statements as a result of new information or future events or
developments.) DATASOURCE: Conor Medsystems, Inc. CONTACT: Michael
Boennighausen, Chief Financial Officer, +1-650-614-4100 Web site:
http://www.conormed.com/
Copyright
Conor Medsystems (NASDAQ:CONR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Conor Medsystems (NASDAQ:CONR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Conor Medsystems (NASDAQ): 0 recent articles
Más de Conor Medsystems (MM) Artículos de Noticias